Of the active trials in the Alzheimer's Disease pipeline, 84 percent were for drugs and six percent were for biologicals, as of 2022. This statistic depicts the number of active trials for Alzheimer’s Disease products in the global pipeline as of 2022, by product type.
Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type
Characteristic
Share of active trials
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IQVIA, & EFPIA. (August 29, 2022). Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA, und EFPIA. "Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type." Chart. August 29, 2022. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA, EFPIA. (2022). Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA, and EFPIA. "Share of Active Trials for Alzheimer’s Disease in The Global Pipeline as of 2022, by Product Type." Statista, Statista Inc., 29 Aug 2022, https://www.statista.com/statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA & EFPIA, Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type Statista, https://www.statista.com/statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/ (last visited July 22, 2024)
Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type [Graph], IQVIA, & EFPIA, August 29, 2022. [Online]. Available: https://www.statista.com/statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/